Literature DB >> 6297931

Brain catecholamine metabolites and behavior in morphine withdrawal.

A C Swann, J D Elsworth, D S Charney, D M Jablons, R H Roth, D E Redmond, J W Maas.   

Abstract

Morphine withdrawal behavior, brain and plasma catecholamine metabolites, and brain beta-noradrenergic receptor binding were examined after acute treatment with naloxone in rats treated with morphine pellets or a sham pelleting procedure. Increases in brain 3-methoxy-4-hydroxyphenethyleneglycol (MHPG), a norepinephrine metabolite, occurred in parallel with rated withdrawal behavior. Withdrawal behavior correlated significantly with brain, and, more modestly, with plasma levels of MHPG but did not correlate with beta-receptor binding or HVA. The effectiveness of debrisoquin sulfate was variable, but the reductions in withdrawal signs and cerebral cortex MHPG were strongly correlated. These data support a direct relationship between presynaptic noradrenergic hyperactivity and opiate withdrawal behavior.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6297931     DOI: 10.1016/0014-2999(82)90314-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

Review 1.  Neuropharmacologic correlates of deglutition: lessons from fictive swallowing.

Authors:  D Bieger
Journal:  Dysphagia       Date:  1991       Impact factor: 3.438

Review 2.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

3.  Simultaneous measurement of biogenic amines and their metabolites in rat brain regions after acute administration of and abrupt withdrawal from butorphanol or morphine.

Authors:  H Wakabayashi; S Tokuyama; I K Ho
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

4.  Effect of clonidine, nimodipine and diltiazem on the in vitro opioid withdrawal response in the guinea-pig ileum.

Authors:  M J Alfaro; M I Colado; F López; M I Martín
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

5.  Heroin increases the density and sensitivity of platelet alpha 2-adrenoceptors in human addicts.

Authors:  J A Garcia-Sevilla; L Ugedo; I Ulibarri; M Gutierrez
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Effects of alpha 2-agonists on morphine withdrawal behaviour: potentiation of jumping mediated by alpha 2-receptors.

Authors:  J W van der Laan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

7.  Effects of naloxone-precipitated withdrawal after a single dose of morphine on catecholamine concentrations in guinea-pig brain.

Authors:  P J Brent; L A Chahl
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

8.  Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain.

Authors:  Elisabeth J Van Bockstaele; Yaping Qian; Robert C Sterling; Michelle E Page
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-03-25       Impact factor: 5.067

9.  Changes induced by sodium cromoglycate in brain catecholamine turnover in morphine dependent and abstinent mice.

Authors:  O San-Martín-Clark; B Cuéllar; J De Alba; J C Leza; P Lorenzo
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

10.  Effect of peripheral administration of cinnarizine and verapamil on the abstinence syndrome in diazepam-dependent rats.

Authors:  Y Chugh; N Saha; A Sankaranarayanan; P L Sharma
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.